Cargando…
Suberoylanilide Hydroxamic Acid Induces Hypersensitivity to Radiation Therapy in Acute Myelogenous Leukemia Cells Expressing Constitutively Active FLT3 Mutants
Histone deacetylase inhibitors (HDIs) have shown promise as candidate radiosensitizer for many types of cancers. However, the mechanisms of action are not well understood, and whether they could have clinical impact on radiotherapy for leukemia is unclear. In this study, we demonstrate that suberoyl...
Autores principales: | Chen, Xufeng, Radany, Eric H., Wong, Patty, Ma, Shenglin, Wu, Kan, Wang, Bing, Wong, Jeffrey Y. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868602/ https://www.ncbi.nlm.nih.gov/pubmed/24367670 http://dx.doi.org/10.1371/journal.pone.0084515 |
Ejemplares similares
-
Suberoylanilide hydroxamic acid enhances the radiosensitivity of lung
cancer cells through acetylated wild-type and mutant p53-dependent modulation of
mitochondrial apoptosis
por: Wu, Kan, et al.
Publicado: (2021) -
Epigenetic therapy potential of suberoylanilide hydroxamic acid on invasive human non-small cell lung cancer cells
por: Zhang, Shirong, et al.
Publicado: (2016) -
Mechanisms of suberoylanilide hydroxamic acid inhibition of mammary cell growth
por: Said, Thenaa K, et al.
Publicado: (2001) -
Suberoylanilide hydroxamic acid represses glioma stem-like cells
por: Hsu, Che-Chia, et al.
Publicado: (2016) -
ING5‐mediated antineuroblastoma effects of suberoylanilide hydroxamic acid
por: Wu, Ji‐cheng, et al.
Publicado: (2018)